Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons?

Area of Science:

• Neuroscience
• Toxicology
• Stem Cell Biology

Background:

• Current in vivo neurotoxicity testing is costly, slow, ethically problematic, and unsuitable for high-throughput chemical screening.
• Existing in vitro methods using human cells face challenges like poor characterization, long differentiation times, and batch variability.
• Commercially available human induced pluripotent stem cell (iPSC)-derived neurons present a potential solution to these limitations.

Purpose of the Study:

• To evaluate the suitability of commercially available human iPSC-derived neurons for neurotoxicity testing.
• To characterize the neuronal composition and functional activity of these iPSC-derived cultures.
• To assess their potential as an alternative to animal models in chemical screening.

Main Methods:

• Immunofluorescent staining to identify neuronal subtypes within iPSC cultures.
• Multi-well microelectrode array (mwMEA) recordings to assess spontaneous neuronal activity.
• Single-cell calcium imaging to confirm the presence and function of key receptors and ion channels.

Main Results:

• Human iPSC-derived neurons from various suppliers form mixed neuronal cultures with diverse neuron types.
• These cultures exhibit developing spontaneous neuronal activity that can be modulated by various compounds.
• Functional GABA, glutamate, acetylcholine receptors, and voltage-gated calcium channels are present and active.

Conclusions:

• Commercially available human iPSC-derived neuronal cultures are suitable for in vitro prioritization and effect screening of chemicals.
• While not yet a full replacement for animal models, they offer a rapidly differentiating, physiologically relevant, animal-free alternative.
• Further validation is needed for large-scale implementation in neurotoxicity testing.